DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» PDE10
PDE10
Multimodal Treatment Strategies in Huntington's Disease
Phosphodiesterase (PDE)
Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights Since 2016
Dopamine Response Gene Pathways in Dorsal Striatum Msns from a Gene Expression Viewpoint: Camp‑Mediated Gene Networks Vladimir N
Dual Activation of Phosphodiesterase 3 and 4 Regulates Basal Cardiac Pacemaker Function and Beyond
Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
Radiosynthesis of Carbon-11 Labeled PDE5 Inhibitors As New Potential PET Radiotracers for Imaging of Alzheimer's Disease Fugui
Cardiac Camp-PKA Signaling Compartmentalization in Myocardial Infarction
Phosphodiesterase-9 (PDE9) Inhibition with BAY 73-6691 Increases Corpus Cavernosum Relaxations Mediated by Nitric Oxide–Cyclic GMP Pathway in Mice
(PDE9): Chances and Challenges Against Neurodegeneration
Functional Characterisation of Phosphodiesterase 4D7 in Prostate Cancer
Phosphodiesterase 11: a Brief Review of Structure, Expression and Function
Characterization of the First Potent and Selective PDE9 Inhibitor Using A
Download File
Phosphodiesterase 10A Cell-Based Assay and Sequences
(12) Patent Application Publication (10) Pub. No.: US 2007/0032404 A1 Sweet (43) Pub
A Novel Target for Selective Inhibition of Colon Tumor Cell Growth and &Beta
Expression of Cgmp-Specific Phosphodiesterase 9A Mrna In
Top View
The Phosphodiesterase 10 Inhibitor Papaverine Exerts Anti-Inflammatory
Inhibition of Phosphodiesterase - 10A by Papaverine Protects Human Cortical Neurons 2 from Quinolinic Acid Induced Oxidative Stress and Synaptic Proteins Alterations
Studies in Beta Cells and Adipocytes in the Context of Obesity and T2D - Focusing on PDE3B, OPN and Scfas
Activation of Phosphodiesterase Type 2 to Treat Heart Failure Marta Lindner
Switch-Like PKA Responses in the Nucleus of Striatal Neurons Cédric Yapo1, Anu G
Cyclic Nucleotide Phosphodiesterases (Pdes) in Smooth Muscle: Expression, Function and Mechanism
Pharmacodynamic Biomarkers for HTT-Lowering Therapies a White Paper
OFF Mechanisms 5 1
High Biochemical Selectivity of Tadalafil, Sildenafil and Vardenafil for Human Phosphodiesterase 5A1 (PDE5) Over PDE11A4 Suggest
The HD-Domain Metalloprotein Superfamily: an Apparent Common Protein Scaffold with Diverse Chemistries
Crystal Structure of Phosphodiesterase 9 Shows Orientation Variation of Inhibitor 3-Isobutyl-1- Methylxanthine Binding
As of May 2, 2017
OFF Mechanisms 5 1
Mechanism for the Allosteric Regulation of Phosphodiesterase 2A Deduced from the X-Ray Structure of a Near Full-Length Construct
ADVANCED PARTNERSHIP PLATFORM for EARLY DRUG DISCOVERY FRAMEWORK of PRODUCTS and SERVICES Lifechemicals.Com
Role of Phosphodiesterase in the Biology and Pathology of Diabetes
Generation and Characterization of Transgenic Mice for Noninvasive Cell Tracking with PET and for FRET-Based Cgmp Imaging.”
N-Terminal Regulatory Domains of Phosphodiesterases 1, 4, 5 and 10 Examined with an Adenylyl Cyclase As a Reporter
Osu1124189520.Pdf (937.93
Identification of Biologically Active PDE11-Selective Inhibitors Using a Yeast-Based High-Throughput Screen
Striatal Phosphodiesterase 10A Availability Is Altered Secondary To